Summary: The SEC’s verdict in the Theranos case raises broader questions on how much leeway to give startup founders and when controls need to be put in place.<br><hr><p style="color:grey;font-size:0.75em;"> Hosted on Acast. See <a style="color:grey;" target="_blank" rel="noopener noreferrer" href="https://acast.com/privacy">acast.com/privacy</a> for more information.</p>
